Balazs Hegedüs

24PUBLICATIONS
71CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Oct 28, 2025
Dual HDAC and PI3K Inhibitor CUDC-907 Inhibits Growth of Pleural Mesothelioma: The Impact of Cisplatin Sensitivity and Myc Expression.

Luca Hegedüs, Silvia Qaisieh, Christian Stülpnagel

|Feb 25, 2025
BCL-B Promotes Lung Cancer Invasiveness by Direct Inhibition of BOK.

Palaniappan Ramesh, Amal R Al Kadi, Gaurav M Borse

|Mar 14, 2024
Evolutionary trajectories of small cell lung cancer under therapy.

Julie George, Lukas Maas, Nima Abedpour

|Jan 26, 2024
Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.

Marcell Baranyi, Eszter Molnár, Luca Hegedűs

|Jun 21, 2023
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.

Berta Mosleh, Karin Schelch, Thomas Mohr

Pageof 4

Frequent Collaborators

9 joint publications

Clemens Aigner

6 joint publications

Michael Grusch

4 joint publications

Walter Berger

3 joint publications

Servet Bölükbas